BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory

Haystack Sciences (acquired by Insitro)

Haystack declares that synthesized some of the most diverse and drug-like chemical libraries on earth. Haystack utilizes the nDexer™ platform for compound ranking and provides a rapid refinement of compounds libraries. Haystack applies machine learning to develop a model of ligand-protein interactions. With their proprietary methods, Haystack discovers drugs for difficult-to-treat disorders.


Posts Mentioning This Company

A Market Review of DNA-encoded Libraries Technology in Drug Discovery

  
(Last updated: October 05, 2022) The interest of pharma organizations in DNA-encoded chemical libraries (DEL) technology has been growing over the years, with numerous pharma organizations now having their internal screening programs using DELs or outsourcing capabilities from specialized DEL providers. This report provides a bird's view of the DEL …